Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer
NCT07517107
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DIAGNOSTIC_TEST:
Circulating Tumor DNA (ctDNA) Analysis
DRUG:
Standard Systemic Therapy for Gastric Cancer
Sponsor
Fudan University